Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Metreleptin clinical trials
15 selected ClinicalTrials.gov records carrying the official matched intervention Metreleptin (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
15 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 15 selected PubMed records and 1 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00025883
PeptideScanner retained ClinicalTrials.gov record NCT00025883 at 2026-11-16T17:35:38.955Z. Its registry update date was 2016-08-16, and PeptideScanner's reviewed identity mapping was metreleptin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- August 16, 2016
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00085982
PeptideScanner retained ClinicalTrials.gov record NCT00085982 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-01-30, and PeptideScanner's reviewed identity mapping was metreleptin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- January 30, 2025
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00461552
PeptideScanner retained ClinicalTrials.gov record NCT00461552 at 2026-11-16T17:35:38.955Z. Its registry update date was 2019-05-09, and PeptideScanner's reviewed identity mapping was metreleptin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- May 9, 2019
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Metreleptin · 2026-11-09
ClinicalTrials.gov record NCT02262806
Active, not recruiting at the retained observation.
Open attributed record →Metreleptin · 2026-10-27
ClinicalTrials.gov record NCT02262832
Active, not recruiting at the retained observation.
Open attributed record →Metreleptin · 2026-07-29
ClinicalTrials.gov record NCT06305182
Recruiting at the retained observation.
Open attributed record →Metreleptin · 2026-07-16
ClinicalTrials.gov record NCT02325674
Recruiting at the retained observation.
Open attributed record →Metreleptin · 2026-07-16
ClinicalTrials.gov record NCT06679270
Recruiting at the retained observation.
Open attributed record →Metreleptin · 2025-11-26
ClinicalTrials.gov record NCT04026178
Completed at the retained observation.
Open attributed record →Metreleptin · 2025-07-03
ClinicalTrials.gov record NCT06484868
Recruiting at the retained observation.
Open attributed record →Metreleptin · 2025-06-12
ClinicalTrials.gov record NCT05351164
Active, not recruiting at the retained observation.
Open attributed record →Metreleptin · 2025-01-30
ClinicalTrials.gov record NCT00085982
Active, not recruiting at the retained observation.
Open attributed record →Metreleptin · 2020-11-24
ClinicalTrials.gov record NCT02654977
Completed at the retained observation.
Open attributed record →Metreleptin · 2020-02-13
ClinicalTrials.gov record NCT00657605
Completed at the retained observation.
Open attributed record →Metreleptin · 2020-02-13
ClinicalTrials.gov record NCT00659828
Completed at the retained observation.
Open attributed record →Metreleptin · 2019-05-09
ClinicalTrials.gov record NCT00461552
Completed at the retained observation.
Open attributed record →Metreleptin · 2017-06-14
ClinicalTrials.gov record NCT01679197
Completed at the retained observation.
Open attributed record →Metreleptin · 2016-08-16
ClinicalTrials.gov record NCT00025883
Completed at the retained observation.
Open attributed record →